The hallucinogenic drug DMT (dimethyltriptamine) could provide crucial aid to stroke victims by minimizing the damage inflicted on victims’ brains as they are rushed to the hospital, according to researchers. Canadian company Algernon Pharmaceuticals has laid out plans to microdose participants in the first clinical trial of its kind in hopes to help stroke victims’ …
The post BIG PHARMA Stroke Victims to Be Given Psychedelic Drug DMT in First-Ever US Clinical Trials appeared first on Educate Inspire Change.